Table 3.
Top 50 Epilepsy over Control proteins with 2× or better sera and 1.5 or better MS/MS hits.
| Symbol | Epilepsy: Control | Symbol | Epilepsy: Control | Symbol | Epilepsy: Control |
|---|---|---|---|---|---|
| [#Sera (#Hits)] | [#Sera (#Hits)] | [#Sera (#Hits)] | |||
| FBN3 | 6(62): 0(0) | PEAR1 1,2 | 4(44): 1(3) | ITGAE 1,2,3 | 3(32): 0(0) |
| MUC17 4 | 6(83): 3(15) | ALPK2 1 | 4(38): 1(10) | ATP8B2 | 3(30): 0(0) |
| SLIT2 1,3 | 5(65): 0(0) | PKD1 1,4 | 4(27): 1(9) | ZNF562 | 3(30): 0(0) |
| PCM1 1,4 | 5(72): 1(6) | DACT2 1 | 4(22): 1(9) | ADAMTSL1 2 | 3(28): 0(0) |
| OTOGL | 5(39): 2(10) | FBXL17 | 4(13): 1(3) | SLC4A4 1,3,4,5 | 3(28): 0(0) |
| ARAP1 1,2 | 4(137): 0(0) | HSPG2 1,2,4,5 | 4(83): 2(23) | ADAMTS12 1,2 | 3(26): 0(0) |
| USP19 1 | 4(135): 0(0) | LAMA2 1,2,3,5 | 4(67): 2(30) | CNST 1 | 3(25): 0(0) |
| CTCFL | 4(126): 0(0) | CEP350 1,2 | 4(33): 2(12) | KLHL4 | 3(25): 0(0) |
| SCARF1 2 | 4(86): 0(0) | NACA 1 | 4(14): 2(9) | KCNQ2 1,3,4,5 | 3(24): 0(0) |
| FAT4 1,3 | 4(83): 0(0) | LCE1A 2 | 3(178): 0(0) | NBPF10 | 3(24): 0(0) |
| CNOT10 | 4(52): 0(0) | ADAM11 1,2,3,4,5 | 3(87): 0(0) | BIN3 1,2,3 | 3(23): 0(0) |
| CLINT1 1,2 | 4(46): 0(0) | VPS13D 1,2,3 | 3(66): 0(0) | AMBN 2 | 3(22): 0(0) |
| CEP152 | 4(43): 0(0) | ADAMTS18 1 | 3(50): 0(0) | BCL11A | 3(22): 0(0) |
| OCA2 1,3,4 | 4(32): 0(0) | ISM2 | 3(34): 0(0) | ABCA12 2 | 3(21): 0(0) |
| AKAP11 1,4 | 4(29): 0(0) | P2RX7 1,2,3,4,5 | 3(34): 0(0) | ZNRF3 1 | 3(21): 0(0) |
| LAMA3 2 | 4(102): 1(21) | POTED | 3(33): 0(0) | SLIT1 1 | 3(20): 0(0) |
| EPHB2 1,2,3,4 | 4(62): 1(12) | PCNX2 1,3 | 3(33): 0(0) |
1 neurological; 2 immune/inflammation; 3 seizure/epilepsy related (shaded); 4 ion-channel related; 5 blood–brain barrier related.